Tuesday, June 2, 2015

Immune-Based Drug Shows Potential Against Another Form of Lung Cancer

Findings suggest lung cancer develops through

Patients with squamous cell non-small cell lung cancer who got nivolumab lived longer, had fewer side effects

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)